Millie
your market intelligence analyst
Search Results
Edit Save
159,986 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
Business Korea (Korea) 05/28/2020 23:43
[비지니스코리아=정민희 기자] 한미약품이 간편하게 복용하는 경구용 치질약인 ‘치쏙정(디오스민600mg)’을 내달 출시한다.작년 출시한 일회용 바르는 치질약 ‘치쏙크림’과 병용할 수 있는 제품으로 치질치료제 라인업을 강화해 환자들의 불편함을 적극 해소한다는 계획이다.치쏙정의 주성분인 디오스민은 약해진 혈관벽을 강화하고 혈관 기능을 회복시키며, 염증 반응을 억제해 통증 및 붓기를 줄이는 효과가 있어 다양한 혈관질환 치료에 사용된다. 또 치질뿐만 아니라 정맥부전(venous insufficiency)으로 인한 다리 통증과 부종 등의 개선.
Splash 247 05/28/2020 23:42
With an estimated value of $400bn, the trade in illicit drugs is a high stakes business whose operatives eagerly exploit vulnerabilities in the legitimate supply chain. Mark Smith, loss prevention executive at North P&I Club, explores recent developments in risk. Given their global reach and lighter security than aircraft, ships are an attractive target for […]
在第四个“全国科技工作者日”到来之际,中共中央总书记、国家主席、中央军委主席习近平5月29日给袁隆平、钟南山、叶培建等25位科技工作者代表回信,向他们并向全国科技工作者致以诚挚的问候。
Interfax-Ukraine (Ukraine) 05/28/2020 23:38
В деле о растрате средств на ремонт служебного автотранспорта в Харьковском ГУ Нацполиции появился третий подозреваемый - один из действующих заместителей начальника полицейского главка.
MUKOMUKO, Bengkuluekspress.com – Masih dalam suasana Idul Fitri dan pandemi Covid-19, Bupati Mukomuko, Choirul Huda didampingi Sekda Marjohan dan para pejabat bersilaturahmi mengunjungi OPD – OPD. Tujuannya memberikan semangat baru kepada Aparatur Sipil Negara (ASN) agar tetap produktifitas bekerja menjalankan tugas melayani masyarakat dengan penuh semangat dan dedikasi yang tinggi serta selalu memperhatikan protokoler kesehatan. .
Business Wire 05/28/2020 23:35
SIOUX FALLS, Dakota du Sud--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), une société biopharmaceutique de stade clinique dont la technologie propriétaire produit des anticorps polyclonaux entièrement humains sans avoir recours à des donneurs de plasma humain, a annoncé aujourd’hui que des données in vitro avaient démontré que SAB-185, son candidat thérapeutique contre la COVID-19, possède des anticorps neutralisants extrêmement puissants dirigés contre le SARS-CoV-2 qui sont quatre fois supérieu.

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles